Figures & data
Figure 1. Rationales for offering conservative treatment or watchful waiting in non-metastatic patients in the Vestfold Mortality Study (N = 117). *Positive lymph nodes were diagnosed by surgical lymph node staging. According to national treatment protocols, at the time positive lymph nodes were a contraindication for radical treatment.
![Figure 1. Rationales for offering conservative treatment or watchful waiting in non-metastatic patients in the Vestfold Mortality Study (N = 117). *Positive lymph nodes were diagnosed by surgical lymph node staging. According to national treatment protocols, at the time positive lymph nodes were a contraindication for radical treatment.](/cms/asset/8c49770d-dbc3-437a-b8d7-e89172561a60/isju_a_1732463_f0001_c.jpg)
Figure 2. Charlson Comorbidity Index (CCI, left) and ECOG performance status (right) at diagnosis for patients with non-metastatic prostate cancer who received no local treatment due to age (NoTreat/Age, N = 43).
![Figure 2. Charlson Comorbidity Index (CCI, left) and ECOG performance status (right) at diagnosis for patients with non-metastatic prostate cancer who received no local treatment due to age (NoTreat/Age, N = 43).](/cms/asset/16bc8279-3354-476b-b04b-e62aa17aeffd/isju_a_1732463_f0002_c.jpg)
Table 1. Characteristics of all patients with non-metastatic PC at diagnosis, who later died of PC and who received no local treatment (n = 117).